Pfizer’s Blood Cancer Therapy Succeeds in Late-Stage Trial
Pfizer announced that its drug, Adcetris, extended survival in patients with the most common type of lymphoma in a late-stage study, bolstering efforts to expand the use of the treatment…
Read More